Primary Site >> Pancreatic Cancer

Gene >> AXL

Journal: J Exp Clin Cancer Res. 2004 Jun;23(2):263-8.
Title: Strong association of ARK5 with tumor invasion and metastasis.
Author: Kusakai, G|Suzuki, A|Ogura, T|Kaminishi, M|Esumi, H
PMID: 15354411
Journal: Cancer Biol Ther. 2009 Apr;8(7):618-26. Epub 2009 Apr 22.
Title: The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
Author: Koorstra, Jan-Bart M|Karikari, Collins A|Feldmann, Georg|Bisht, Savita|Rojas, Pamela Leal|Offerhaus, G Johan A|Alvarez, Hector|Maitra, Anirban
PMID: 19252414
Journal: Cancer. 2011 Feb 15;117(4):734-43.
Title: Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.
Author: Song, Xianzhou|Wang, Hua|Logsdon, Craig D|Rashid, Asif|Fleming, Jason B|Abbruzzese, James L|Gomez, Henry F|Evans, Douglas B|Wang, Huamin
PMID: 20922806
Journal: Oncogene. 2013 Jul 18;32(29):3420-31.
Title: Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
Author: Linger, R M A|Cohen, R A|Cummings, C T|Sather, S|Migdall-Wilson, J|Middleton, D H G|Lu, X|Baron, A E|Franklin, W A|Merrick, D T|Jedlicka, P|DeRyckere, D|Heasley, L E|Graham, D K
PMID: 22890323
Journal: Biochim Biophys Acta. 2013 Dec;1833(12):2856-65.
Title: Calix[6]arene bypasses human pancreatic cancer aggressiveness: downregulation of receptor tyrosine kinases and induction of cell death by reticulum stress and autophagy.
Author: Pelizzaro-Rocha, Karin Juliane|de Jesus, Marcelo Bispo|Ruela-de-Sousa, Roberta Regina|Nakamura, Celso Vataru|Reis, Fabiano Souza|de Fatima, Angelo|Ferreira-Halder, Carmen Verissima
PMID: 23872419
Journal: Eur J Med Chem. 2014 Nov 24;87:745-58.
Title: A new goniothalamin N-acylated aza-derivative strongly downregulates mediators of signaling transduction associated with pancreatic cancer aggressiveness.
Author: Barcelos, Rosimeire Coura|Pelizzaro-Rocha, Karin Juliane|Pastre, Julio Cezar|Dias, Marina Pereira|Ferreira-Halder, Carmen Verissima|Pilli, Ronaldo Aloise
PMID: 25305718
Journal: Oncotarget. 2014 Oct 30;5(20):9546-63.
Title: AXL kinase as a novel target for cancer therapy.
Author: Wu, Xiaoliang|Liu, Xuewen|Koul, Sanjay|Lee, Chang Youl|Zhang, Zhenfeng|Halmos, Balazs
PMID: 25337673
Journal: Mol Cell Proteomics. 2014 Nov;13(11):2803-11.
Title: Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics.
Author: Kim, Min-Sik|Zhong, Yi|Yachida, Shinichi|Rajeshkumar, N V|Abel, Melissa L|Marimuthu, Arivusudar|Mudgal, Keshav|Hruban, Ralph H|Poling, Justin S|Tyner, Jeffrey W|Maitra, Anirban|Iacobuzio-Donahue, Christine A|Pandey, Akhilesh
PMID: 24895378
Journal: Biochem Biophys Res Commun. 2014 Jan 10;443(2):635-40.
Title: Imaging Axl expression in pancreatic and prostate cancer xenografts.
Author: Nimmagadda, Sridhar|Pullambhatla, Mrudula|Lisok, Ala|Hu, Chaoxin|Maitra, Anirban|Pomper, Martin G
PMID: 24333418
Journal: Oncogene. 2014 Nov 20;33(47):5405-14.
Title: Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.
Author: Leconet, W|Larbouret, C|Chardes, T|Thomas, G|Neiveyans, M|Busson, M|Jarlier, M|Radosevic-Robin, N|Pugniere, M|Bernex, F|Penault-Llorca, F|Pasquet, J-M|Pelegrin, A|Robert, B
PMID: 24240689
Journal: Cancer Res. 2015 Mar 15;75(6):1091-101.
Title: Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.
Author: Pettazzoni, Piergiorgio|Viale, Andrea|Shah, Parantu|Carugo, Alessandro|Ying, Haoqiang|Wang, Huamin|Genovese, Giannicola|Seth, Sahil|Minelli, Rosalba|Green, Tessa|Huang-Hobbs, Emmet|Corti, Denise|Sanchez, Nora|Nezi, Luigi|Marchesini, Matteo|Kapoor, Avnish|
PMID: 25736685
Journal: Cancer Res. 2015 Sep 15;75(18):3699-705.
Title: Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.
Author: Kirane, Amanda|Ludwig, Kathleen F|Sorrelle, Noah|Haaland, Gry|Sandal, Tone|Ranaweera, Renate|Toombs, Jason E|Wang, Miao|Dineen, Sean P|Micklem, David|Dellinger, Michael T|Lorens, James B|Brekken, Rolf A
PMID: 26206560
Journal: Adv Clin Exp Med. 2016 May-Jun;25(3):531-7.
Title: Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
Author: Jiang, Chengyi|Zhou, Lei|Wang, Hongtao|Zhang, Qiang|Xu, Yajia
PMID: 27629742
Journal: Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):486-489.
Title: Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Author: Rao, Avani D|Liu, Yufei|von Eyben, Rie|Hsu, Charles C|Hu, Chen|Rosati, Lauren M|Parekh, Arti|Ng, Kendall|Hacker-Prietz, Amy|Zheng, Lei|Pawlik, Timothy M|Laheru, Daniel A|Jaffee, Elizabeth M|Weiss, Matthew J|Le, Dung T|Hruban, Ralph H|De Jesus-Acosta, Ana|
PMID: 29157747
Journal: Cancer Res. 2018 Jan 1;78(1):246-255.
Title: Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.
Author: Ludwig, Kathleen F|Du, Wenting|Sorrelle, Noah B|Wnuk-Lipinska, Katarzyna|Topalovski, Mary|Toombs, Jason E|Cruz, Victoria H|Yabuuchi, Shinichi|Rajeshkumar, N V|Maitra, Anirban|Lorens, James B|Brekken, Rolf A
PMID: 29180468
Journal: Life Sci. 2018 Apr 1;198:99-111.
Title: Axl inhibitors as novel cancer therapeutic agents.
Author: Shen, Yingying|Chen, Xiguang|He, Jun|Liao, Duanfang|Zu, Xuyu
PMID: 29496493
Journal: Expert Opin Ther Targets. 2018 Sep 23.
Title: Does Axl have potential as a therapeutic target in pancreatic cancer?
Author: Du, Wenting|Brekken, Rolf A
PMID: 30244621